Clinical Trial Update: Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing lenalidomide to methotrexate for difficult-to-treat cutaneous lupus erythematosus, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• Lenalidomide (lenalidomide)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cutaneous Lupus Erythematosus (CLE) | Phase 3 | Status: NOT_YET_RECRUITING